Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype
- 7 August 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (4) , 984-989
- https://doi.org/10.1016/s0006-291x(03)01507-9
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (RG200007)
This publication has 18 references indexed in Scilit:
- all- trans -Retinoic Acid Increases Nitric Oxide Synthesis by Endothelial CellsCirculation Research, 2002
- Angiogenesis Is Impaired by HypercholesterolemiaCirculation, 2000
- Lipophilization of somatostatin analog RC‐160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitroBritish Journal of Pharmacology, 2000
- Intracellular localization of dimethylarginine dimethylaminohydrolase overexpressed in an endothelial cell lineActa Physiologica Scandinavica, 2000
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine KinasesJournal of Medicinal Chemistry, 1998
- Functional Characterization of the Spontaneously Transformed Human Umbilical Vein Endothelial Cell Line ECV304: Use in anin VitroModel of AngiogenesisExperimental Cell Research, 1996
- Protein methylationCurrent Opinion in Cell Biology, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Metabolism of NG,NG- and NG,NG-dimethylarginine in ratsArchives of Biochemistry and Biophysics, 1987